Clinical trial NCT01565265 - References

Complications Associated With Artificial Fertilization — Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression

Citation(s)

•   Al-Inany H, Aboulghar M
  GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod. 2002 Apr;17(4):874-85.
•   Burgués S; Spanish Collaborative Group on Female Hypogonadotrophic Hypogonadism
  . The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain. Hum Reprod. 2001 Dec;16(12):2525-32.
•   Coppola F, Potì ER, Barusi L, Ferrari B, Salvarani MC, Vadora E
  Profound luteinizing hormone suppression induces a deleterious follicular environment during assisted reproduction technology. Fertil Steril. 2003 Feb;79(2):459-60.
•   Griesinger G, Felberbaum R, Diedrich K
  GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry. Hum Reprod. 2005 Sep;20(9):2373-5. Epub 2005 Jun 2.
•   Huirne JA, Hugues JN, Pirard C, Fischl F, Sage JC, Pouly JL, Obruca A, Braat DM, van Loenen AC, Lambalk CB
  Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF/ICSI patients treated with r-hFSH: a randomized, multicentre, phase IIIb study. Hum Reprod. 2006 Jun;21(6):1408-15. Epub 2006 Mar 14.
•   Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K, Griesinger G
  Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update. 2006 Nov-Dec;12(6):651-71. Epub 2006 Aug 18. Review.
•   Kolibianakis EM, Zikopoulos K, Schiettecatte J, Smitz J, Tournaye H, Camus M, Van Steirteghem AC, Devroey P
  Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF. Hum Reprod. 2004 Nov;19(11):2490-6. Epub 2004 Aug 19.
•   Merviel P, Antoine JM, Mathieu E, Millot F, Mandelbaum J, Uzan S
  Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer. Fertil Steril. 2004 Jul;82(1):119-25.
•   Peñarrubia J, Fábregues F, Creus M, Manau D, Casamitjana R, Guimerá M, Carmona F, Vanrell JA, Balasch J
  LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH. Hum Reprod. 2003 Dec;18(12):2689-97.
•   Pouly JL, Bachelot A, de Mouzon J, Devaux A; FIVNAT
  . [Comparison of agonists versus antagonists for i.v.f. stimulation: the French FIVNAT survey 2001-2002]. Gynecol Obstet Fertil. 2004 Sep;32(9):737-40. French.
•   Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study
  The European Recombinant Human LH Study Group. J Clin Endocrinol Metab. 1998 May;83(5):1507-14.

Prospective Randomized Study Comparing Ovarian Stimulation With Pergoveris Supported by a GnRH Agonist in a Long Protocol Versus Multidose GnRH Antagonist Regimen in Young Infertile Women Treated With ICS

Details for clinical trial NCT01565265